President Trump made an excellent choice on Friday in nominating Dr. Scott Gottlieb to be Commissioner of the Food and Drug Administration. Gottlieb, a medical doctor and former FDA deputy commissioner, knows from experience how FDA's culture and its ever-increasing demands for more extensive clinical testing delay access to life-saving treatments.
If confirmed, he has an opportunity to shake up a system that has lost sight of what its goal should be — to help patients receive access to better drugs, sooner, at lower cost.
Read Full Article »